Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/1993
02/18/1993WO1993003134A1 Process for isolating and purifying recombinant interleukin-7
02/18/1993WO1993003062A1 Method of preferential labelling of a phycobiliprotein with a second dye to enable multiple color assay
02/18/1993WO1993003061A1 Hematopoietic stem cell multiplier
02/18/1993WO1993003060A1 Amide derivatives of antibiotic a 40926
02/18/1993WO1993003058A2 NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS
02/18/1993WO1993003057A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p.falciparum, related products and their use in producing vaccine compositions
02/18/1993WO1993003056A1 Lanthionine bridged peptides
02/18/1993WO1993003050A1 Novel cyclophilins, associating proteins and uses
02/18/1993WO1993003035A1 Anti-hiv drug
02/18/1993WO1993002708A1 Novel reagent for tumour imaging and therapy
02/18/1993WO1993002704A1 Mixture of peptide constituents having vaccinating properties against paludism particularly due to plasmodium falciparum
02/18/1993WO1993002702A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma
02/18/1993WO1993002698A1 Monoclonal antibodies to leukocyte adhesion molecule-1
02/18/1993WO1993002696A1 T-cell membrane protein for b cell ig class switching
02/18/1993WO1993002694A1 Retinol-binding receptor and complex
02/18/1993WO1993002693A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
02/18/1993WO1993002691A1 Steroid hormone drug delivery
02/18/1993WO1993002690A1 Diagnosis and treatment of autoimmune diseases
02/18/1993WO1993002654A2 A method of inducing hemoglobin synthesis in red blood cells and uses therefor
02/18/1993WO1992014696A3 SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES
02/18/1993DE4127256A1 Chromatographic isolation of proteins from e.g. blood esp. cytochrome C sepn. - by contacting with buffered macroporous cellulose@ beads, rinsing away impurities and eluting adsorbed proteins with different buffer
02/18/1993CA2115246A1 Lanthionine bridged peptides
02/18/1993CA2115061A1 Method of isolation of dna
02/18/1993CA2114950A1 Treatment of cell populations
02/18/1993CA2114942A1 Novel cyclophilins, associating proteins and uses
02/18/1993CA2114647A1 Diagnosis and treatment of autoimmune diseases
02/18/1993CA2114409A1 Nucleotide sequences coding for ribosome inactivating proteins
02/18/1993CA2114223A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p. falciparum, related products and their use in producing vaccine compositions
02/18/1993CA2114220A1 Immunoassay for the simultaneous detection of hiv-1, hiv-2, htlv-i and htlv-ii antibodies
02/18/1993CA2114112A1 Transgenic protein production
02/18/1993CA2114103A1 Device for detecting aqueous contaminants
02/18/1993CA2113837A1 Anti-hiv agent
02/18/1993CA2113551A1 Highly stable recombinant yeasts for the production of recombinant proteins
02/18/1993CA2112566A1 Non-desensitizing analogs of gnrh and other biologically active ligands
02/18/1993CA2111116A1 Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein
02/18/1993CA2110505A1 Infectious bursal disease virus recombinant poxvirus vaccine
02/18/1993CA2092542A1 Hemopoietic stem cell multiplier
02/18/1993CA2083273A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma
02/17/1993EP0527212A1 Analyte determination in biological fluids in the presence of interfering substances.
02/17/1993EP0514488A4 Retinoid receptor compositions and methods
02/17/1993EP0245479B1 Shortened phosphoglycerate kinase promoter
02/17/1993CN1069068A Recombinant avipox virus, culture of cells infected by this virus and vaccines for poultry derived from this virus
02/17/1993CA2075685A1 Chromophore containing compounds and their use in determining interleukin-1b convertase activity
02/17/1993CA2075662A1 Chromophore containing compounds and their use in determining interleukin-1b convertase activity
02/16/1993US5187268 Gene encoding an anti-complement protein from vaccinia
02/16/1993US5187267 DNA sequence for genetic transcription and generation of transformed plants
02/16/1993US5187263 Genetically engineered, platelet derived growth factor protein
02/16/1993US5187262 Pure protein from clones DNA siimilar to that found in the latex of the Rubber Tree; binding of chitin; fungicides
02/16/1993US5187261 Peptide sequence of first seven amino acids of lambda bacteriophage protein fused to human serum albumin
02/16/1993US5187158 Brain-specific drug delivery
02/16/1993US5187157 Peptide boronic acid inhibitors of trypsin-like proteases
02/16/1993US5187155 For inhibiting activation of Factor X
02/16/1993US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives
02/16/1993US5187151 Use of binding protein with igf-i as an anabolic growth promoting agent
02/16/1993US5187098 DNA encoding hybrid streptokinases with plasminogen fibrin binding domains
02/16/1993US5187091 Bacillus thuringiensis cryiiic gene encoding toxic to coleopteran insects
02/16/1993US5187090 For tumor diagnosis
02/16/1993US5187089 Variants wherein there are nonpolar amino acid substitutions at the substrate binding site
02/16/1993US5187087 Recominbant herpesvirus of turkeys and live vector vaccines derived thereof
02/16/1993US5187086 Molecules with antibody combining sites that catalyze hydrolysis reactions through use of a charged hapten
02/16/1993US5187080 For inducing immune response in chickens
02/16/1993US5187079 Glucose-repressible gene for the regulated expression of proteins and expression vector therefor
02/16/1993US5187077 Leukaemia inhibitory factor
02/16/1993US5187076 DNA sequences encoding BMP-6 proteins
02/16/1993US5187075 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses
02/16/1993US5187063 Combining a muscle sample with antibodies which specifically bind to glycoprotein component of dystrophin/glycoprotein complex, detecing extent of binding and comparing with extent of binding in nondystrophic muscle tissue samples
02/16/1993US5187061 Transducing particles and methods for their production
02/16/1993US5186934 Bacillus thuringiensis gene encoding a coleopteran-active toxin
02/16/1993US5186933 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
02/16/1993US5186931 Composition and method for supporting bone marrow transplantation
02/16/1993US5186513 Softshell
02/16/1993CA2049275A1 Purification of sf hemoglobin
02/15/1993CA2076064A1 Derivatives of human haemoglobin, method for preparing them, products derived therefrom and use of these derivatives and products
02/14/1993WO1993004165A1 DNA SEQUENCE ENCODING BOVINE α-LACTALBUMIN AND METHODS OF USE
02/11/1993DE4126484A1 Anti-sense-RNA expression vectors - contain hybrid promoter sequences and viral DNA sequences i.e. HIV, in anti-sense direction, useful in prodn. of HIV-resistant cells
02/10/1993EP0527063A1 Production of protein of interest in the milk of transgenic mammal
02/10/1993EP0527056A1 Novel reagent for tumour imaging and therapy
02/10/1993EP0526953A1 Multichain polypeptides or proteins and processes for their production
02/10/1993EP0526952A2 Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same
02/10/1993EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them
02/10/1993EP0526883A2 Chondromodulin-II protein
02/10/1993EP0526544A1 Therapeutic uses of actin-binding compounds
02/10/1993EP0526472A1 Household general-purpose adhesive on a polyurethane basis.
02/10/1993EP0526452A1 Hybrid immunoglobulins
02/10/1993EP0403524B1 Preparation of nitruro compounds usable as radio-pharmaceutical products
02/10/1993EP0396563B1 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
02/10/1993EP0167548B1 Cloning of cdna and expression of murine-interleukin-3
02/10/1993CN1068744A Asialoglycoprotein-conjugated medicinal agent
02/10/1993CA2075611A1 Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody, and detection systems
02/09/1993WO1993002697A1 Production of peptide amides
02/09/1993US5185444 Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
02/09/1993US5185441 Polypeptides that bind to CD2, the receptor on the surface of T-cells
02/09/1993US5185440 cDNA clone coding for Venezuelan equine encephalitis virus and attenuating mutations thereof
02/09/1993US5185438 Genetic engineering
02/09/1993US5185432 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas
02/09/1993US5185431 Isolated, purified glyoprotein factor having antitumor activity
02/09/1993US5185430 Protein isolated from surface of mammalian or fish cells
02/09/1993US5185324 Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof
02/09/1993US5185323 Administering to reduce number of circulating platelets in bloodstream of mammals
02/09/1993US5185321 Adding lysozyme to Lactobeicillus, incubating, hydrolyzing peptidoglycans, centriguging, adding to whey or fermented milk